Chugai Pharmaceutical Co., Ltd. Share Price
Stocks
4519
JP3519400000
Pharmaceuticals
OTC Markets Traded|
Delayed
Japan Exchange
07:30:00 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 6,885.00 JPY | +0.55% |
|
-4.16% | -16.47% |
| 08-18 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| 08-14 | Japanese shares climb on bets Fed to hold rates steady; Topix poised for record close | RE |
| Market Cap | 11,265B 70.58B 60.96B 57.35B 52.13B 98.04B 6,762B 99.48B 673B 264B 3,382B 265B 259B | P/E 2026 * |
22.2x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 10,355B 64.88B 56.03B 52.72B 47.92B 90.12B 6,216B 91.44B 618B 242B 3,109B 244B 238B | EV / Sales 2026 * |
7.46x | EV / Sales 2027 * | 6.6x |
| Free-Float |
38.12% | Yield 2026 * |
1.99% | Yield 2027 * | 2.27% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +0.55% | ||
| 1 week | -4.16% | ||
| Current month | -0.68% | ||
| 1 month | -6.92% | ||
| 3 months | -13.24% | ||
| 6 months | -28.24% | ||
| Current year | -16.47% |
| 1 week | 6,831 |  | 7,229 |
| 1 month | 6,575 | | 7,509 |
| Current year | 6,575 | | 10,700 |
| 1 year | 6,002 | | 10,700 |
| 3 years | 4,197 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 28/02/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 27/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 29/02/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 27/03/2024 |
| Director/Board Member | 51 | 28/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | -4.16% | +5.29% | +62.84% | 70.58B | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,093B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 653B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 458B | |
| +0.79% | -0.41% | +39.89% | +43.14% | 355B | |
| +0.40% | +1.55% | +25.00% | +40.13% | 294B | |
| +0.78% | +1.84% | +1.14% | +11.64% | 248B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 230B | |
| -1.42% | -2.30% | -15.93% | -53.60% | 203B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 178B | |
| Average | +1.62% | -0.26% | +27.71% | +50.96% | 378.1B | |
| Weighted average by Cap. | +2.37% | +0.18% | +42.98% | +68.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,389B 8.7B 7.51B 7.07B 6.43B 12.09B 834B 12.26B 82.93B 32.5B 417B 32.66B 31.95B | 1,533B 9.61B 8.3B 7.81B 7.09B 13.34B 920B 13.54B 91.56B 35.88B 460B 36.06B 35.28B |
| Net income | 507B 3.18B 2.74B 2.58B 2.35B 4.41B 304B 4.48B 30.29B 11.87B 152B 11.93B 11.67B | 588B 3.68B 3.18B 2.99B 2.72B 5.12B 353B 5.19B 35.11B 13.76B 176B 13.83B 13.53B |
| Net Debt | -910B -5.7B -4.93B -4.63B -4.21B -7.92B -546B -8.04B -54.36B -21.3B -273B -21.41B -20.94B | -1,152B -7.22B -6.23B -5.86B -5.33B -10.03B -691B -10.17B -68.79B -26.96B -346B -27.1B -26.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | JP¥6,885.00 | +0.55% | 3,127,400 |
| 18/08/26 | JP¥6,847.00 | -0.25% | 2,180,500 |
| 17/08/26 | JP¥6,864.00 | -1.00% | 1,900,800 |
| 14/08/26 | JP¥6,933.00 | -3.37% | 4,618,700 |
| 13/08/26 | JP¥7,175.00 | -0.13% | 2,369,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
